BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31119567)

  • 21. Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis.
    Brieu N; Gavriel CG; Nearchou IP; Harrison DJ; Schmidt G; Caie PD
    Sci Rep; 2019 Mar; 9(1):5174. PubMed ID: 30914794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A machine learning-based prognostic predictor for stage III colon cancer.
    Jiang D; Liao J; Duan H; Wu Q; Owen G; Shu C; Chen L; He Y; Wu Z; He D; Zhang W; Wang Z
    Sci Rep; 2020 Jun; 10(1):10333. PubMed ID: 32587295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning.
    Kim I; Choi HJ; Ryu JM; Lee SK; Yu JH; Kim SW; Nam SJ; Lee JE
    Eur J Surg Oncol; 2019 Feb; 45(2):134-140. PubMed ID: 30348602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using machine learning to create prognostic systems for endometrial cancer.
    Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hu J; Hur C; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Dec; 159(3):744-750. PubMed ID: 33019982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of breast cancer risk using a machine learning approach embedded with a locality preserving projection algorithm.
    Heidari M; Khuzani AZ; Hollingsworth AB; Danala G; Mirniaharikandehei S; Qiu Y; Liu H; Zheng B
    Phys Med Biol; 2018 Jan; 63(3):035020. PubMed ID: 29239858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
    Pinto AE; Pereira T; Silva GL; André S
    Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR imaging features associated with distant metastasis-free survival of patients with invasive breast cancer: a case-control study.
    Song SE; Shin SU; Moon HG; Ryu HS; Kim K; Moon WK
    Breast Cancer Res Treat; 2017 Apr; 162(3):559-569. PubMed ID: 28185146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial.
    Schmidt M; Victor A; Bratzel D; Boehm D; Cotarelo C; Lebrecht A; Siggelkow W; Hengstler JG; Elsässer A; Gehrmann M; Lehr HA; Koelbl H; von Minckwitz G; Harbeck N; Thomssen C
    Ann Oncol; 2009 Feb; 20(2):258-64. PubMed ID: 18824499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
    Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
    Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMP-1 expression has an independent prognostic value in breast cancer.
    Boström P; Söderström M; Vahlberg T; Söderström KO; Roberts PJ; Carpén O; Hirsimäki P
    BMC Cancer; 2011 Aug; 11():348. PubMed ID: 21835023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer.
    Zeindler J; Angehrn F; Droeser R; Däster S; Piscuoglio S; Ng CKY; Kilic E; Mechera R; Meili S; Isaak A; Weber WP; Muenst S; Soysal SD
    Breast Cancer Res Treat; 2019 Oct; 177(3):581-589. PubMed ID: 31267330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
    Miller P; Kidwell KM; Thomas D; Sabel M; Rae JM; Hayes DF; Hudson BI; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2017 Nov; 166(1):85-94. PubMed ID: 28717852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study.
    Huang B; Tian S; Zhan N; Ma J; Huang Z; Zhang C; Zhang H; Ming F; Liao F; Ji M; Zhang J; Liu Y; He P; Deng B; Hu J; Dong W
    EBioMedicine; 2021 Nov; 73():103631. PubMed ID: 34678610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting factors for survival of breast cancer patients using machine learning techniques.
    Ganggayah MD; Taib NA; Har YC; Lio P; Dhillon SK
    BMC Med Inform Decis Mak; 2019 Mar; 19(1):48. PubMed ID: 30902088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
    Tian Y; Li J; Zhou T; Tong D; Chi S; Kong X; Ding K; Li J
    BMC Cancer; 2018 Nov; 18(1):1084. PubMed ID: 30409119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothesis-free deep survival learning applied to the tumour microenvironment in gastric cancer.
    Meier A; Nekolla K; Hewitt LC; Earle S; Yoshikawa T; Oshima T; Miyagi Y; Huss R; Schmidt G; Grabsch HI
    J Pathol Clin Res; 2020 Oct; 6(4):273-282. PubMed ID: 32592447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
    Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
    Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors on outcomes in metaplastic breast cancer.
    Leyrer CM; Berriochoa CA; Agrawal S; Donaldson A; Calhoun BC; Shah C; Stewart R; Moore HCF; Tendulkar RD
    Breast Cancer Res Treat; 2017 Oct; 165(3):499-504. PubMed ID: 28689362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.